UCLA DGSOM, UCLA Health, UCLA Semel Institute — Los Angeles, California

UCLA DGSOM, UCLA Health, UCLA Semel Institute is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA DGSOM, UCLA Health, UCLA Semel Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Treatment-resistant Schizophrenia.

Sponsors: Newron Pharmaceuticals SPA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA DGSOM, UCLA Health, UCLA Semel Institute?

UCLA DGSOM, UCLA Health, UCLA Semel Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA DGSOM, UCLA Health, UCLA Semel Institute conducted?

UCLA DGSOM, UCLA Health, UCLA Semel Institute has 1 clinical trials on record, with 1 currently active. Their work covers Treatment-resistant Schizophrenia.

Is UCLA DGSOM, UCLA Health, UCLA Semel Institute accredited by Crixeo Health?

UCLA DGSOM, UCLA Health, UCLA Semel Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA DGSOM, UCLA Health, UCLA Semel Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.